Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Geriatric medicine

Beta-blockers risk functional decline in some older patients

Nursing home residents with pre-existing cognitive or functional impairments were at a higher risk of functional decline after taking beta-blockers following acute myocardial infarction, study shows.

Beta-blockers are a cornerstone of treatment following acute myocardial infarction, but many older nursing home residents don’t receive them owing to concerns over functional harms, such as dizziness, fatigue and depression.

Reporting their findings in JAMA Internal Medicine[1] (online, 12 December 2016), researchers studied 5,496 nursing home residents who began taking a beta-blocker after an acute myocardial infarction, matched to an equal number of residents with similar characteristics who did not receive beta-blockers.

Among those with pre-existing substantial cognitive or functional impairment, beta-blocker users had a 34% increased risk of functional decline. But functional decline was unaffected by beta-blocker use in those with relatively preserved baseline cognition and function. Mortality was 26% lower in beta-blocker users and this was similar across all subgroups.

The researchers conclude that this trade-off between functional harms and mortality benefits should be resolved on individual patient preferences rather than generally withholding beta-blocker treatment for older patients.

Citation: The Pharmaceutical Journal DOI: 10.1211/CP.2017.20202217

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Sport and Exercise Medicine for Pharmacists

    Sport and Exercise Medicine for Pharmacists

    All the information you need to provide patients with evidence-based advice on sports and exercise related health matters.

    £27.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • Popular Medicines

    Popular Medicines

    An illustrated history of some of the most popular branded medicines. Includes colourful historical adverts and details of the medicine's formula and intended purpose.

    £22.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Close-up of pills on an elderly person's hands

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.